| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.075 | 0.2 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.075 | 0.2 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.075 | 0.2 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |